Healthcare provider profile · identity verified

Clayton Timothy Pierce

Osteopathic Manipulative Medicine · PHOENIX, AZ · NPI 1235691593

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	360	126
Levothyroxine Sodium	Levothyroxine Sodium	313	99
Lisinopril	Lisinopril	271	92
Metformin Hcl	Metformin Hcl	263	90
Losartan Potassium	Losartan Potassium	232	82
Amlodipine Besylate	Amlodipine Besylate	213	78
Gabapentin	Gabapentin	200	73
Tamsulosin Hcl	Tamsulosin Hcl	184	62
Albuterol Sulfate Hfa	Albuterol Sulfate	165	55
Fluticasone Propionate	Fluticasone Propionate	163	68
Omeprazole	Omeprazole	150	56
Pantoprazole Sodium	Pantoprazole Sodium	146	50
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	126	45
Hydrochlorothiazide	Hydrochlorothiazide	118	40
Rosuvastatin Calcium	Rosuvastatin Calcium	114	39
Zolpidem Tartrate	Zolpidem Tartrate	111	28
Furosemide	Furosemide	105	41
Hydroxyzine Hcl	Hydroxyzine Hcl	100	45
Tramadol Hcl	Tramadol Hcl	97	32
Ozempic	Semaglutide	91	21
Metoprolol Succinate	Metoprolol Succinate	87	31
Montelukast Sodium	Montelukast Sodium	86	32
Pravastatin Sodium	Pravastatin Sodium	86	24
Potassium Chloride	Potassium Chloride	78	29
Eliquis	Apixaban	76	23
Trazodone Hcl	Trazodone Hcl	76	28
Meloxicam	Meloxicam	74	28
Naproxen	Naproxen	73	34
Ondansetron Odt	Ondansetron	70	26
Metoprolol Tartrate	Metoprolol Tartrate	69	19
Sertraline Hcl	Sertraline Hcl	64	24
Pioglitazone Hcl	Pioglitazone Hcl	62	23
Duloxetine Hcl	Duloxetine Hcl	58	23
Alendronate Sodium	Alendronate Sodium	56	23
Lorazepam	Lorazepam	55	15
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	55	14
Carvedilol	Carvedilol	53	21
Symbicort	Budesonide/Formoterol Fumarate	52	suppressed
Finasteride	Finasteride	51	15
Alprazolam	Alprazolam	50	23
Glimepiride	Glimepiride	50	13
Temazepam	Temazepam	49	suppressed
Simvastatin	Simvastatin	47	18
Triamcinolone Acetonide	Triamcinolone Acetonide	47	28
Atenolol	Atenolol	46	13
Escitalopram Oxalate	Escitalopram Oxalate	46	17
Allopurinol	Allopurinol	44	14
Ibuprofen	Ibuprofen	43	16
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	43	31
Amitriptyline Hcl	Amitriptyline Hcl	42	11
Tizanidine Hcl	Tizanidine Hcl	42	17
Citalopram Hbr	Citalopram Hydrobromide	41	suppressed
Glipizide	Glipizide	36	15
Jardiance	Empagliflozin	36	12
Propranolol Hcl	Propranolol Hcl	36	12
Trulicity	Dulaglutide	36	suppressed
Valacyclovir	Valacyclovir Hcl	34	12
Prednisone	Prednisone	33	12
Azelastine Hcl	Azelastine Hcl	32	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	32	suppressed
Januvia	Sitagliptin Phosphate	32	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	32	12
Clopidogrel	Clopidogrel Bisulfate	30	14
Famotidine	Famotidine	29	16
Meclizine Hcl	Meclizine Hcl	29	13
Pregabalin	Pregabalin	28	12
Quetiapine Fumarate	Quetiapine Fumarate	28	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	28	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	28	suppressed
Xarelto	Rivaroxaban	28	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	27	11
Ketoconazole	Ketoconazole	27	suppressed
Baclofen	Baclofen	26	suppressed
Bupropion Xl	Bupropion Hcl	26	suppressed
Carbamazepine Er	Carbamazepine	26	suppressed
Clonazepam	Clonazepam	26	suppressed
Fenofibrate	Fenofibrate	26	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	26	14
Warfarin Sodium	Warfarin Sodium	26	suppressed
Diclofenac Sodium	Diclofenac Sodium	25	14
Metformin Hcl Er	Metformin Hcl	25	13
Acyclovir	Acyclovir	24	suppressed
Azithromycin	Azithromycin	24	14
Spironolactone	Spironolactone	24	suppressed
Celecoxib	Celecoxib	23	suppressed
Mirtazapine	Mirtazapine	23	suppressed
Valsartan	Valsartan	23	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Neomycin-Polymyxin-Hc	Neomycin/Polymyxin B/Hydrocort	22	17
Sildenafil Citrate	Sildenafil Citrate	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	21	suppressed
Farxiga	Dapagliflozin Propanediol	21	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	21	suppressed
Lovastatin	Lovastatin	21	suppressed
Methylprednisolone	Methylprednisolone	21	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	20	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Synthroid	Levothyroxine Sodium	20	suppressed
Ciclopirox	Ciclopirox	19	suppressed
Diazepam	Diazepam	19	suppressed
Ezetimibe	Ezetimibe	19	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Oxycodone Hcl	Oxycodone Hcl	19	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Clotrimazole	Clotrimazole	18	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	18	17
Benazepril Hcl	Benazepril Hcl	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Estradiol	Estradiol	17	suppressed
Irbesartan	Irbesartan	17	suppressed
Mupirocin	Mupirocin	17	16
Buspirone Hcl	Buspirone Hcl	16	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	16	suppressed
Donepezil Hcl	Donepezil Hcl	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Rizatriptan	Rizatriptan Benzoate	14	suppressed
Topiramate	Topiramate	14	suppressed
Tresiba Flextouch U-100	Insulin Degludec	14	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Ibu	Ibuprofen	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Methimazole	Methimazole	13	suppressed
Midodrine Hcl	Midodrine Hcl	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Butalbital-Aspirin-Caffeine	Butalbital/Aspirin/Caffeine	12	suppressed
Carisoprodol	Carisoprodol	12	suppressed
Cephalexin	Cephalexin	12	suppressed
Cimetidine	Cimetidine	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Tadalafil	Tadalafil	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Fenofibrate	Fenofibrate,micronized	11	suppressed
Lactulose	Lactulose	11	suppressed
Linzess	Linaclotide	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Risperidone	Risperidone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error